Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -2.283% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CN1C(=O)CSc2ccc(NC(=O)N3CCc4ccccc43)cc21
b) Cc1ccccc1CN1Cc2cccc3c2[C@@H](CC1=O)[C@H](O)[C@H](O)C3
c) Cc1cc(C)n2nc(C)c(Br)c2n1
d) O=C(Nc1ccc(N2CCN(C(=O)c3cccs3)CC2)cc1)c1cccc(F)c1
e) Cc1ccc(C(=O)N/C(=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)C(=O)NC(C)(C)C)cc1
Answer: a. CN1C(=O)CSc2ccc(NC(=O)N3CCc4ccccc43)cc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(=O)CSc2ccc(NC(=O)N3CCc4ccccc43)cc21
CN1C(=O)CSc2ccc(NC(=O)N3CCc4ccccc43)cc21
N-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)-2,3-dihydroindole-1-carboxamide